| Market Size in 2024 | Market Forecast in 2034 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 485.63 Million | USD 1,203.50 Million | 9.50% | 2024 |
FrequentlyAsked Questions
Electronic brachytherapy (eBx) is a form of radiotherapy. It utilizes a miniaturized high-dose-rate (HDR) X-ray source to apply radiation directly to the cancerous site.
The global electronic brachytherapy market is expected to be driven by the rising use of the treatment method against skin lesions.
According to study, the global electronic brachytherapy market size was worth around USD 485.63 million in 2024 and is predicted to grow to around USD 1,203.50 million by 2034.
The CAGR value of the electronic brachytherapy market is expected to be around 9.50% during 2025-2034.
The global electronic brachytherapy market is expected to be driven by North America during the forecast period.
The global electronic brachytherapy market is led by players like Sensus Healthcare Inc., Xoft Inc. (iCAD subsidiary), Varian Medical Systems Inc. (Siemens Healthineers), CivaTech Oncology Inc., C4 Imaging LLC, iCAD Inc., Becton, Dickinson and Company (C.R. Bard / BD), Theragenics Corporation, CIVCO Medical Solutions, Panacea Medical Technologies Pvt. Ltd., Elekta AB, Concure Oncology, Eckert & Ziegler BEBIG, Argon Medical Devices Inc., and IsoRay Inc.
The report explores crucial aspects of the electronic brachytherapy market, including a detailed discussion of existing growth factors and restraints, while also browsing future growth opportunities and challenges that impact the market.
HappyClients